The 73rd Annual Meeting of the Japanese Society for Virology

*Mei Hashizume¹, Mai Hayasaka^1,2, Masaharu Iwasaki^1,2,3,4 (1. Research Institute for Microbial Diseases, The university of Osaka, 2. Center for Advanced Modalities and Drug Delivery System, The University of Osaka, 3. Center for Infectious Disease Education and Research, The University of Osaka, 4. RNA Frontier Science Division, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka)

*Reo Igarashi^1,2, Devinda S. Muthusinghe¹, Tomoko Tsuruta¹, Manabu Igarashi⁴, Shuzo Urata^1,2,3 (1. National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, 2. Graduate School of Biomedical Sciences, Nagasaki University, 3. Institute of Tropical Medicine (NEKKEN), Nagasaki University, 4. International Institute for Zoonosis Control, Hokkaido University,)

*Yukiko Muramoto^1,2, Koji Yamauchi^1,2, Kazuya Houri^1,2, Maya Yamane¹, Chiho Onishi¹, Hou-Chen Lee^1,3, Allison Groseth⁴, Shuzo Urata⁵, Thomas Strecker⁶, Takeshi Noda^1,2 (1. Institute for Life and Medical Sciences, Kyoto University, 2. Graduate School of Biostudies, Kyoto University, 3. Biomedical Translation Research Center & Institute of Biomedical Sciences, Academia Sinica, Taiwan, 4. Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Germany, 5. National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, 6. Institute of Virology, Phillips University Marburg, Germany)

*THUY THI NGOC DUONG^1,2, Michihito Sasaki^3,4, Yasuko Orba^3,4,5, Osamu Ichii^6,7, Keisuke Maezono^1,8, Haruto Eguchi¹, Cherry Mae Senoron Bariwa¹, Savit Promwattanapan¹, Satoru Konnai^4,7,8,9, Shintaro Kobayashi^1,4,7,8, Hiroaki Kariwa^1,8 (1. Laboratory of Public Health, Graduate School of Infectious Diseases, Hokkaido University, Japan, 2. Department of Microbiology and Immunology, Tay Nguyen Institute of Hygiene and Epidemiology, Vietnam., 3. Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Japan, 4. Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Japan, 5. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Japan, 6. Laboratory of Anatomy, Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Japan, 7. One Health Research Center, Hokkaido University, Japan, 8. Veterinary Research Unit, International Institute for Zoonosis Control, Hokkaido University, Japan, 9. Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Japan)

*Yume Mimura¹, Takahiro Hiono^2,6,7,8, Hiromu Arakawa³, Shiori Go³, Asako Shigeno¹, Mebuki Ito¹, Eri Fujii⁴, Keita Mizuma^1,5, Yasuko Orba^4,7,8, Hiroyuki Kaji³, Keita Matsuno^1,2,7,8 (1. Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, 2. One Health Research Center, Hokkaido University, 3. Institute for Glyco-core Research (iGCORE), Nagoya University, 4. Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, 5. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (The UTOPIA Center), Institutes for Advanced Study, The University of Tokyo, 6. Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, 7. Institute for Vaccine Research and Development, HU IVReD, Hokkaido University, 8. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University)